Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/29/19 | S-3 | Registration statement for specified transactions by certain issuers |
|
33 | |
| 08/29/19 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
57 | |
| 08/29/19 | 8-K | Current report filing |
|
69 | |
| 08/23/19 | 8-K | Current report filing |
|
3 | |
| 08/21/19 | DEF 14A | Definitive proxy statements |
|
31 | |
| 08/14/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
147 |
| 08/14/19 | 8-K | Current report filing |
|
3 | |
| 08/02/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/02/19 | SC TO-I/A | Issuer tender offer statement |
|
3 | |
| 08/02/19 | 8-K | Current report filing |
|
4 |
